HomeComparePCRB vs NOBL

PCRB vs NOBL: Dividend Comparison 2026

PCRB yields 9.42% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCRB wins by $14.5K in total portfolio value
10 years
PCRB
PCRB
● Live price
9.42%
Share price
$46.72
Annual div
$4.40
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.3K
Annual income
$1,704.18
Full PCRB calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — PCRB vs NOBL

📍 PCRB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCRBNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCRB + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PCRB pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRB
Annual income on $10K today (after 15% tax)
$800.53/yr
After 10yr DRIP, annual income (after tax)
$1,448.55/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, PCRB beats the other by $1,239.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRB + NOBL for your $10,000?

PCRB: 50%NOBL: 50%
100% NOBL50/50100% PCRB
Portfolio after 10yr
$30.1K
Annual income
$975.18/yr
Blended yield
3.24%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRB buys
0
NOBL buys
0
No recent congressional trades found for PCRB or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCRBNOBL
Forward yield9.42%2.14%
Annual dividend / share$4.40$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$37.3K$22.8K
Annual income after 10y$1,704.18$246.19
Total dividends collected$13.2K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PCRB vs NOBL ($10,000, DRIP)

YearPCRB PortfolioPCRB Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,642$941.80$10,914$214.34+$728.00PCRB
2$13,481$1,024.70$11,897$218.63+$1.6KPCRB
3$15,534$1,108.99$12,952$222.72+$2.6KPCRB
4$17,816$1,194.25$14,086$226.62+$3.7KPCRB
5$20,343$1,280.06$15,302$230.33+$5.0KPCRB
6$23,133$1,366.01$16,607$233.85+$6.5KPCRB
7$26,204$1,451.74$18,007$237.18+$8.2KPCRB
8$29,575$1,536.89$19,508$240.35+$10.1KPCRB
9$33,267$1,621.13$21,116$243.35+$12.2KPCRB
10$37,299$1,704.18$22,841$246.19+$14.5KPCRB

PCRB vs NOBL: Complete Analysis 2026

PCRBStock

The fund seeks high current income. The fund invests mainly in a diversified portfolio of investment-grade fixed-income securities with a focus on companies or issuers that the fund's investment manager believes meet relevant environmental, social or governance (ESG) criteria on a sector-specific basis.

Full PCRB Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this PCRB vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRB vs SCHDPCRB vs JEPIPCRB vs OPCRB vs KOPCRB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.